Rahima Jamal
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 26
- Cancer Immunotherapy and Biomarkers 24
- Colorectal Cancer Treatments and Studies 6
- CAR-T cell therapy research 6
- Peptidase Inhibition and Analysis 3
-
- Melanoma and MAPK Pathways 7
- Co-authors
- Wilson H. Miller (10 shared papers)Meriem Messaoudene (4 shared papers)Karl Bélanger (8 shared papers)Philip Wong (4 shared papers)Arielle Elkrief (4 shared papers)Bertrand Routy (4 shared papers)Wiam Belkaïd (2 shared papers)Corentin Richard (1 shared paper)
- Journals
- Journal of Clinical Oncology (18 papers)Cancer Research (3 papers)Investigational New Drugs (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Scientific Reports (1 paper)
- Partner nations
- CanadaUnited StatesSouth Korea
In The Last Decade
Rahima Jamal
31 papers receiving 405 citations
Peers
Comparison fields: 5 of 56
- Oncology 303
- Immunology 106
- Otorhinolaryngology 18
- Molecular Biology 184
- Infectious Diseases 49
Countries citing papers authored by Rahima Jamal
This map shows the geographic impact of Rahima Jamal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahima Jamal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahima Jamal more than expected).
Fields of papers citing papers by Rahima Jamal
This network shows the impact of papers produced by Rahima Jamal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahima Jamal. The network helps show where Rahima Jamal may publish in the future.
Co-authors
The 25 scholars most cited alongside Rahima Jamal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 152 | |
| 2 | 2019 | 40 | |
| 3 | 2017 | 38 | |
| 4 | 2017 | 23 | |
| 5 | 2021 | 17 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 11 | |
| 8 | 2013 | 10 | |
| 9 | 2020 | 9 | |
| 10 | 2024 | 9 | |
| 11 | 2017 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2024 | 7 | |
| 14 | 2014 | 7 | |
| 15 | 2017 | 7 | |
| 16 | 2022 | 6 | |
| 17 | 2018 | 6 | |
| 18 | 2018 | 5 | |
| 19 | 2020 | 5 | |
| 20 | 2023 | 5 |
About Rahima Jamal
Rahima Jamal is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Infectious Diseases and Otorhinolaryngology, having authored 33 papers that have together received 408 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (24 papers), Melanoma and MAPK Pathways (7 papers), Colorectal Cancer Treatments and Studies (6 papers), CAR-T cell therapy research (6 papers), Head and Neck Cancer Studies (5 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Immunotherapy and Immune Responses (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Oncology (303 citations), Immunology (106 citations), Otorhinolaryngology (18 citations), Molecular Biology (184 citations) and Infectious Diseases (49 citations). Rahima Jamal has collaborated with scholars based in Canada, United States and South Korea. Frequent co-authors include Wilson H. Miller, Meriem Messaoudene, Karl Bélanger, Philip Wong, Arielle Elkrief, Bertrand Routy, Wiam Belkaïd, Corentin Richard, Nathalie Letarte and Julie Malo. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Investigational New Drugs, Journal for ImmunoTherapy of Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.